In the pharmaceutical industry, Warfarin is a potent oral anticoagulant and a Vitamin K antagonist. As a pharmacist and manufacturer, I view this molecule as a “Precision Antithrombotic”—it is technically a Narrow Therapeutic Index (NTI) drug, meaning the difference between a therapeutic dose and a toxic (bleeding) dose is extremely small.
At your WHO-GMP facility in Mumbai, Warfarin 5 mg is a high-sensitivity SKU. For your digital platforms, highlighting the necessity of INR (International Normalized Ratio) monitoring is the primary technical safety message.
Therapeutic Profile: Primary Indications
Warfarin 5 mg is used to prevent the formation and migration of blood clots in high-risk cardiovascular and systemic conditions.
| Indication | Clinical Context | Technical Rationale |
| Atrial Fibrillation (AFib) | Stroke Prevention | Prevents clots from forming in the heart’s atria due to irregular heartbeats. |
| DVT & PE | Venous Thromboembolism | Treats and prevents Deep Vein Thrombosis and Pulmonary Embolism. |
| Prosthetic Heart Valves | Post-Surgical Care | Essential for patients with mechanical heart valves to prevent valve-related clots. |
| Myocardial Infarction | Post-Heart Attack | Reduces the risk of recurrent heart attacks or systemic embolic events. |
Mechanism: Vitamin K Antagonism
Warfarin works by “starving” the liver of the active vitamin required to produce clotting factors:
Enzyme Inhibition: It inhibits the enzyme Vitamin K Epoxide Reductase (VKORC1).
Depletion of Factors: This prevents the recycling of Vitamin K, leading to a depletion of Vitamin K-dependent clotting factors (II, VII, IX, and X) and anticoagulant proteins C and S.
Delayed Onset: Technically, Warfarin does not dissolve existing clots; it prevents new ones from forming. Its full effect takes 48 to 72 hours because existing clotting factors must first be cleared from the blood.
The Pharmacist’s “Technical Warning”
The “INR” Mandate: As a pharmacist, I must emphasize that dosing is guided strictly by the INR blood test. For most patients, the target range is 2.0 to 3.0.
Vitamin K Consistency: Patients do not need to avoid green leafy vegetables (high in Vitamin K), but they must keep their intake consistent. A sudden surge in Vitamin K will “cancel out” the Warfarin dose.
The “Bleeding” Red Flag: Any unusual bruising, nosebleeds, or pink-colored urine requires immediate medical attention.
Drug Interactions: Warfarin has a massive interaction profile. Common drugs like Aspirin, NSAIDs, and certain antibiotics can dangerously increase the risk of hemorrhage.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Scored Tablet” USP: On your digital marketplace, highlight the precision scoring of your 5 mg tablets. Since patients often need to adjust doses (e.g., to 2.5 mg or 7.5 mg) based on INR results, accurate tablet splitting is a technical requirement for patient safety.
Color-Coding Standards: Internationally, Warfarin 5 mg is traditionally peach/pink. Maintaining global color-coding standards helps prevent medication errors in B2B export markets.
Stability for Export: Warfarin Sodium is sensitive to light and moisture. Utilizing Alu-Alu blister packaging ensures a 36-month shelf life in Zone IVb tropical regions.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for cardiovascular and geriatric care.